Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredients over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as Epilepsy, Anxiety, Insomnia, Hypertension, and Migraine.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules is a specialized formulation developed by Bayview Pharmacy. This unique blend combines two potent active ingredients, belladonna alkaloids and phenobarbital, to provide long-lasting relief from a range of disease states. These conditions include anxiety, insomnia, seizures, and muscle spasms. The slow-release capsule, formulated with Methocel E4M, a type of controlled-release polymer, ensures that the active ingredients are gradually released over an extended period. This gradual release offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
For healthcare providers, this formulation presents a appropriate treatment option for a variety of conditions. The slow-release capsule ensures that the active ingredients are gradually released over time, providing sustained relief. This formulation is an excellent choice for patients who require long-term relief from their symptoms.
At Bayview Pharmacy, we take pride in offering this unique formulation to our patients and healthcare providers. If you have any questions about this formulation or any of our other products, please do not hesitate to contact us. We are here to assist you.
Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation designed for controlled and prolonged release. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the encapsulated medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.
It's important to note that Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may interact with other medications, including but not limited to anticholinergics, anticonvulsants, sedatives, and other CNS depressants. Therefore, patients are advised to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. This is to ensure the prevention of potential drug-drug interactions.
Furthermore, patients should also be aware of potential drug-disease interactions. Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may interact with certain medical conditions, such as glaucoma, asthma, and urinary retention. Therefore, patients should inform their healthcare provider of any existing medical conditions before starting this medication.
Patients are strongly advised not to take Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules if they are currently on any of the following medications: anticholinergics, anticonvulsants, sedatives, or other CNS depressants. Additionally, patients should avoid alcohol while taking this medication to prevent potential adverse effects.
If you have any questions or concerns about the potential interactions of Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, please consult with your healthcare provider for further information and guidance.
Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation of two potent medications, designed to treat a variety of conditions. The belladonna alkaloids are anticholinergic agents that function by inhibiting the action of acetylcholine, a neurotransmitter that plays a crucial role in muscle contractions. On the other hand, phenobarbital is a barbiturate that operates by depressing the central nervous system.
The unique feature of these capsules is their slow-release mechanism, facilitated by the use of Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only ensures a consistent and prolonged effect but also reduces the frequency of dosing, thereby improving patient compliance, particularly for medications that necessitate a controlled and extended release profile.
These capsules are intended for oral administration and should be taken with a full glass of water. It is crucial to adhere to the prescribed dosage and not to take more or less than the recommended amount. It's worth noting that Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules may induce drowsiness or dizziness. Therefore, activities requiring alertness, such as driving or operating machinery, should be avoided until you are aware of how the medication affects you. Additionally, alcohol consumption should be avoided while on this medication.
If you have any queries or concerns about Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, do not hesitate to seek professional advice. It's important to understand how this medication works and how it can assist in managing your condition.
Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules are a compounded formulation designed to provide sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer that gradually releases the encapsulated medication or active ingredient. This formulation is primarily used to treat conditions such as spasticity, muscle spasms, certain types of pain, and specific types of seizures, including absence seizures. It can also be beneficial in reducing the frequency of seizures in patients with Lennox-Gastaut syndrome.
Furthermore, this formulation may be used to alleviate the severity of withdrawal symptoms in patients who are trying to stop using alcohol or other drugs. However, it is crucial to note that this formulation should not be used to treat any condition other than those specifically listed without first consulting a physician. It is also important to be aware that this formulation may cause side effects such as drowsiness, dizziness, and confusion, and should not be used while operating a motor vehicle or machinery.
If you have any questions or concerns about the use of Belladonna Alkaloids/Phenobarbital 48.6 mg Slow Release Capsules, it is recommended that you seek advice from a healthcare professional.
This is a compounded medication that contains Belladonna Alkaloids and Phenobarbital. It is formulated with Methocel E4M, a type of controlled-release polymer, which allows the medication to be released gradually over an extended period of time.
Methocel E4M is a controlled-release polymer that is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Slow-release formulations offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of this medication will depend on your doctor's prescription. However, due to its slow-release formulation, it is generally required to be taken less frequently than immediate-release medications.
Belladonna Alkaloids and Phenobarbital are used to treat a variety of conditions, including gastrointestinal disorders and symptoms of irritable bowel syndrome. Phenobarbital is also used as a sedative and to control seizures.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, or constipation. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant. Phenobarbital can harm an unborn baby. If you are breastfeeding, consult your doctor before starting this medication as it can pass into breast milk.
Alcohol can increase the nervous system side effects of Phenobarbital such as dizziness, drowsiness, and difficulty concentrating. It is best to avoid or limit the use of alcohol while being treated with this medication.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include severe drowsiness, slow or shallow breathing, severe dizziness, or inability to wake up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
